Autoinhibition and Autoactivation of the DNA Replication Checkpoint Kinase Cds1

Cds1 is the ortholog of Chk2 and the major effector of the DNA replication checkpoint in Schizosaccharomyces pombe. Previous studies have shown that Cds1 is activated by a two-stage mechanism. In the priming stage, the sensor kinase Rad3 and the mediator Mrc1 function to phosphorylate a threonine residue, Thr¹¹, in the SQ/TQ domain of Cds1. In the autoactivation stage, primed Cds1 molecules dimerize via intermolecular interactions between the phosphorylated Thr¹¹ in one Cds1 and the forkhead-associated domain of the other. Dimerization activates Cds1, probably by promoting autophosphorylation. To define the mechanisms for the autoactivation of primed Cds1 and the regulation of this process, we carried out genetic and biochemical studies to identify phosphorylatable residues required for checkpoint activation. Our data indicate that dimerization of Cds1 promotes trans-autophosphorylation of a number of residues in the catalytic domain, but phosphorylation of a highly conserved threonine residue (Thr³²⁸) in the activation loop is the only covalent modification required for kinase activation in vitro and in vivo. Autophosphorylation of Thr³²⁸ and kinase activation in unprimed, monomeric Cds1 are strongly inhibited by the C-terminal 27-amino acid tail of the enzyme. This autoinhibitory effect may play an important role in preventing spontaneous activation of the replication checkpoint during normal cell cycles. The two-stage activation pathway and the autoinhibition mechanism, which are probably shared by other members of the Chk2 family, provide sensitivity, specificity, and noise immunity, properties required for the replication checkpoint.DNA replication forks can be arrested or stalled by damage to DNA templates, depletion of deoxyribonucleotides, or inhibition of replisome enzymes (1). If undetected, arrested or stalled replication forks may undergo collapse, resulting in loss of genetic information, mutagenesis, or even cell death. To maintain the integrity of the genome, eukaryotes have evolved a surveillance mechanism called the “replication checkpoint” that can detect perturbations of DNA replication and elicit a number of cellular responses that serve to mitigate the effects of such perturbations. These cellular responses may include stabilization of replication forks, suppression of initiation of DNA replication, increased DNA repair activity, augmented production of deoxyribonucleotide precursors, and delay of mitosis. The replication checkpoint pathway is essential for cell survival under a variety of stressful conditions and has been conserved from yeast to humans (for reviews, see Refs. 1–3). Mutations in the pathway are also linked to cancer (4–6).The replication checkpoint is a complex signal transduction pathway that can be separated conceptually into three functional components. Sensors detect the perturbed DNA replication forks; mediators transduce the checkpoint signal, whereas effectors regulate the cell cycle and promote cell survival. Genetic studies, especially those in the yeasts, have identified most, if not all, of the essential factors of the pathway. In the fission yeast Schizosaccharomyces pombe, six Rad proteins mediate the sensor function (for reviews, see Refs. 7 and 8). The protein kinase Rad3 (ATR in human cells) binds an essential co-factor Rad26 (ATRIP in human cells), and the complex associates with stalled replication forks. Rad9, Hus1, and Rad1 form the “9-1-1” ring structure similar to that of the replication processivity factor proliferating cell nuclear antigen. Rad17, in association with Rfc2-5, loads the 9-1-1 complex onto DNA at stalled forks. After detection of stalled forks by the sensor complexes, the mediator protein Mrc1 protein (Claspin in human cells) functions to facilitate the Rad3-dependent phosphorylation and activation of the effector protein kinase Cds1 (Chk2 in human cells) (9–11). Studies in Saccharomyces cerevisiae suggest that Mrc1 may be a component of the replisome (12, 13). A second mediator, Crb2 (BRCA1 in human cells) (14, 15), functions in response to DNA damage either within or outside of S phase. Crb2 facilitates the activation of a second effector kinase, Chk1.We have previously reported that in S. pombe, the effector kinase of the replication checkpoint pathway, Cds1, is activated by a two-stage mechanism (11). In the first or priming stage, the sensor kinase Rad3 phosphorylates two functionally redundant Cds1-docking repeats in the middle of the mediator Mrc1. The phosphorylated docking repeats on Mrc1 recruit Cds1 to the stalled replication fork by a phospho-dependent interaction with the forkhead-associated (FHA)3 domain of Cds1. Once recruited to the proximity of the assembled sensor complex, Cds1 is phosphorylated by Rad3 at Thr¹¹. In the second or autoactivation stage, primed Cds1 molecules dimerize by two identical intermolecular interactions between phosphorylated Thr¹¹ and the FHA domain. Dimerization promotes autophosphorylation and activation of Cds1. This two-stage activation mechanism is supported by genetic studies (9, 16–18) and is probably similar to the activation pathway for mammalian Chk2 (19–23). Although many steps in the pathway are now understood, the precise biochemical mechanism of autoactivation of primed Cds1 has not been well defined.Protein kinases can be activated by a variety of mechanisms. Although phosphorylation of the activation loop, usually by an upstream kinase of a signal transduction pathway, is the most common mechanism for kinase activation, some protein kinases can be activated by phosphorylation of residues outside the activation loop (for reviews, see Refs. 24 and 25). Other protein kinases can be activated without phosphorylation (e.g. by intermolecular interactions following dimerization) (26), by removal of an inhibitory element (27), or by binding to an activator (27, 28). Since the autoactivation of primed Cds1 requires dimerization, three possible activation mechanisms can be proposed. First, like many other protein kinases, Cds1 may be activated by phosphorylation of the activation loop (24). There are several known examples of kinase activation via trans-autophosphorylation of the activation loop. In these cases, the activation loop usually contains a consensus phosphorylation site of the kinase itself. This is not the case for Cds1 family kinases. A second possibility is that dimerization of Cds1 may allow intermolecular interactions that promote activation, as has been suggested for the epidermal growth factor receptor (26). Finally, activation of Cds1 may be a consequence of phosphorylation of residue(s) outside the activation loop. In the second and the third models, phosphorylation of the two essential threonine residues in the activation segment observed previously in mammalian Chk2 (22) and in the S. cerevisiae homologue Rad53 (29) would be a by-product, not a cause, of kinase activation.Several previous observations have provided evidence in support of the possibility that activation of Cds1 requires autophosphorylation. First, Cds1 is a phosphoprotein, and hydroxyurea (HU) treatment of cells induces further phosphorylation that is partially dependent on the kinase activity of Cds1 itself.⁴ In the case of mammalian Chk2, the ortholog of Cds1, sites of phosphorylation have been mapped to the activation segment residues, Thr³⁸³ and Thr³⁸⁷ (22, 30), as well as to residues Ser³⁷⁹ (31), Ser⁵¹⁶ (30, 32), and Ser⁴⁵⁶ (33), which lie outside of the activation segment. Phosphorylation has also been mapped by mass spectrometry to sites within and outside of the activation segment of Rad53 (29), the S. cerevisiae homologue of Cds1. Second, genetic studies have shown that residues Thr³²⁸ and Thr³³² in the activation segment of Cds1 (corresponding to Thr³⁸³ and Thr³⁸⁷ of Chk2 and Thr³⁵⁴ and Thr³⁵⁸ of Rad53) are essential for kinase activity (11, 34). Third, phosphatase treatment of “activated Cds1” purified from HU-treated cells abolishes kinase activity (11). Finally, activation of induced Cds1 dimers in vitro is dependent upon ATP (11).In this report, we describe experiments aimed at distinguishing among the three potential mechanisms for Cds1 activation. We show that there are only three phosphorylatable residues in the Cds1 kinase domain (Thr³²⁸, Thr³³², and Tyr³⁵²) that are essential for activation of the replication checkpoint in vivo and for enzyme activity in vitro. Of these three residues, Thr³²⁸ in the activation loop is a target of autophosphorylation, and its phosphorylation is the only covalent modification required for Cds1 activation. Autophosphorylation of Thr³²⁸ occurs in trans and only proceeds at an appreciable rate when the enzyme is at high local concentration. Presumably, one molecule in a Cds1 dimer transiently assumes an active conformation and phosphorylates the Thr³²⁸ in the activation loop of the other molecule. The activated molecule can then rapidly phosphorylate its dimeric partner. The second essential residue, Thr³³², which is also in the activation loop, is not phosphorylated and is likely required, directly or indirectly, for catalysis. The third essential residue Tyr³⁵² can be autophosphorylated in vitro with the Cds1 purified from S. pombe, and its phosphorylation is strongly stimulated by dimerization. However, Tyr³⁵² phosphorylation is not readily observed in vivo and is not required for Cds1 activation. Our data rule out the other two possible mechanisms for Cds1 activation: phosphorylation of sites outside of the activation segment and phosphorylation-independent conformational changes induced by dimerization. We also report that the C terminus of Cds1 is a cis-regulatory element that can dramatically suppress Cds1 autoactivation in vitro and in vivo. Taken together, our data explain how the replication checkpoint can be sensitive and specific and also possess a high threshold for spontaneous activation.